Who owns VIVOS THERAPEUTICS INC?
- Ticker: VVOS
- CUSIP Number: 92859e207
Tip: Access positions for across all investors
Analyze quarterly positions in Vivos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Vivos Therapeutics stock
Who bought or sold VIVOS THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Strategic Wealth Designers | 129k | $1.6M | 100% | Dec 2023 |
|
Schonfeld Strategic Advisors | 50k | $623k | 100% | Dec 2023 |
|
Vanguard Group | 11k | $132k | 100% | Dec 2023 |
|
Newbridge Financial Services Group | 1.3k | $16k | 100% | Dec 2023 |
|
Signature | 547.00 | $6.8k | 100% | Dec 2023 |
|
Kozak & Associates | 49.00 | $351.001700 | 100% | Dec 2023 |
|
Global Retirement Partners | 23.00 | $164.999700 | 100% | Dec 2023 |
|
Steward Partners Investment Advisory | 8.00 | $100.000000 | 100% | Dec 2023 |
|
Wells Fargo & Company | 7.00 | $87.000200 | 100% | Dec 2023 |
|
Royal Bank of Canada | 7.00 | $0 | 100% | Dec 2023 |
|
Who sold out of Vivos Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cutler | Dec 2023 | 12.00 | $0 |